Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	AdiraMedica Hyoscine Butylbromide 10mg
Active Ingredient:	Hyoscine butylbromide 10mg
Dosage Form:	Coated tablet
New Zealand Sponsor:	AdiraMedica Pty Limited
Manufacturer:	Sunglow Lifescience Private Limited, Kattankulam Village, India

*Product:*	AdiraMedica Hyoscine Butylbromide 20mg
Active Ingredient:	Hyoscine butylbromide 20mg
Dosage Form:	Coated tablet
New Zealand Sponsor:	AdiraMedica Pty Limited
Manufacturer:	Sunglow Lifescience Private Limited, Kattankulam Village, India

*Product:*	Cequa
Active Ingredient:	Ciclosporin 0.9mg/mL
Dosage Form:	Eye drops, solution
New Zealand Sponsor:	CARSL Consulting
Manufacturer:	Laboratoire Unither, Coutances, France

*Product:*	Nurofen Meltlets Berry Burst (General sale)
Active Ingredient:	Ibuprofen 200mg
Dosage Form:	Orodispersible tablet
New Zealand Sponsor:	Reckitt Benckiser (New Zealand) Limited
Manufacturer:	Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom

*Product:*	Nurofen Meltlets Berry Burst (Pharmacy only)
Active Ingredient:	Ibuprofen 200mg
Dosage Form:	Orodispersible tablet
New Zealand Sponsor:	Reckitt Benckiser (New Zealand) Limited
Manufacturer:	Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom

Dated this 8th day of February 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule